MB
BLONDON, Marc
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Practice-changing evidence from academic trials in VTE : COBRRA, RENOVE, and API-CAT | VASA | 2025 | 1 | 0 | |||
| Syndromes de Marfan et apparentés | Revue médicale suisse | 2025 | 9 | 0 | |||
| Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis | Annals of internal medicine | 2025 | 1 | 0 | |||
| Preventing Postpartum Venous Thromboembolism With Low-Molecular-Weight Heparin : The PP-HEP Pilot Randomised Controlled Trial | BJOG | 2024 | 201 | 293 | |||
| Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial | Research and practice in thrombosis and haemostasis | 2024 | 72 | 90 | |||
| Angiologie et hémostase : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 106 | 14 | |||
| Santé cardiovasculaire et médecine transgenre | Revue médicale suisse | 2024 | 1 | 0 | |||
| VTE risk assessment and prevention in pregnancy | Hämostaseologie | 2024 | 46 | 386 | |||
| Preferences of pregnant women for postpartum thromboprophylaxis : the bicentric PREFER-PostPartum study | Journal of thrombosis and haemostasis | 2024 | 91 | 97 | |||
| Evidence-based personalized thromboprophylaxis after major arthroplasty : a new horizon | Journal of thrombosis and haemostasis | 2024 | 411 | 0 | |||
| Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort | Swiss medical weekly | 2023 | 89 | 65 | |||
| Angiologie et hémostase : ce qui a changé en 2022 | Revue médicale suisse | 2023 | 119 | 63 | |||
| High-flow arteriovenous fistula resulting from stingray injury | Journal of travel medicine | 2023 | 81 | 1 | |||
| Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives | Blood | 2023 | 114 | 83 | |||
| Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial | Thrombosis research | 2023 | 317 | 68 | |||
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | 2022 | 282 | 399 | |||
| Preventing postpartum venous thromboembolism in 2022 : a narrative review | Frontiers in cardiovascular medicine | 2022 | 89 | 117 | |||
| Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism | Blood | 2022 | 1 | 0 | |||
| Place des anticoagulants oraux directs dans le traitement des thromboses veineuses de localisation inhabituelle | Revue médicale suisse | 2022 | 136 | 103 | |||
| Incident thrombus location and predicting risk of recurrent venous thromboembolism | Research and practice in thrombosis and haemostasis | 2022 | 98 | 121 | |||
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | 2022 | 245 | 249 | |||
| Thromboprophylaxie mécanique hospitalière | Revue médicale suisse | 2022 | 87 | 208 | |||
| Covid-19, anticoagulation et maladie thromboembolique veineuse : qu’a-t-on appris ? | Revue médicale suisse | 2021 | 201 | 87 | |||
| Screening for Cancer in Patients with Acute Venous Thromboembolic Disease | Hämostaseologie | 2021 | 124 | 0 | |||
| Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis | Thrombosis journal | 2021 | 302 | 133 | |||
| Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study | Journal of thrombosis and haemostasis | 2021 | 205 | 0 | |||
| Thromboprophylaxis strategies to improve the prognosis of COVID-19 | Vascular pharmacology | 2021 | 195 | 85 | |||
| Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis | Journal of Thrombosis and Haemostasis | 2021 | 271 | 1 | |||
| Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER) | Thrombosis and haemostasis | 2021 | 147 | 0 | |||
| Management of high-risk pulmonary embolism in pregnancy | Thrombosis research | 2021 | 248 | 175 | |||
| Every 6 seconds in Europe | Thrombosis research | 2021 | 381 | 1 | |||
| Comparative venous thromboembolic safety of oral and transdermal postmenopausal hormone therapies among women Veterans | Menopause | 2021 | 176 | 313 | |||
| Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort | Research and practice in thrombosis and haemostasis | 2021 | 169 | 74 | |||
| Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines | Swiss Medical Weekly | 2020 | 540 | 236 | |||
| Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives | Revue médicale suisse | 2020 | 344 | 201 | |||
| External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort | Journal of Thrombosis and Haemostasis | 2020 | 375 | 1 | |||
| Allergologie-immunologie - Prise en charge de l'artérite gigantocellulaire en 2019 | Revue médicale suisse | 2020 | 482 | 94 | |||
| Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality | Thrombosis research | 2020 | 146 | 0 | |||
| Exciting times for the ISTH early career professionals | Journal of thrombosis and haemostasis | 2020 | 241 | 45 | |||
| Contraception et maladie thromboembolique veineuse | Revue médicale suisse | 2020 | 274 | 210 | |||
| Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: A cost-effectiveness analysis | Journal of thrombosis and haemostasis | 2020 | 185 | 2 | |||
| Évolution de la thromboprophylaxie après prothèses de hanche et de genou | Revue médicale suisse | 2020 | 358 | 1 | |||
| Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration | Journal of thrombosis and haemostasis | 2020 | 190 | 0 | |||
| Understanding and Preventing Placenta-Mediated Pregnancy Complications | Hämostaseologie | 2020 | 139 | 0 | |||
| Thrombin generation and fibrin clot structure after vitamin D supplementation | Endocrine Connections | 2019 | 387 | 171 | |||
| Hospital thromboprophylaxis: one size should not fit all | 2019 | 309 | 3 | ||||
| Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial | Journal of Thrombosis and Haemostasis | 2019 | 303 | 0 | |||
| Thromboprophylaxie en chirurgie gynécologique : vers une prévention cohérente | Revue médicale suisse | 2019 | 451 | 0 | |||
| Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis | Research and practice in thrombosis and haemostasis | 2019 | 153 | 68 | |||
| Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis | Thrombosis Research | 2019 | 353 | 1 | |||
| Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women | Journal of Thrombosis and Haemostasis | 2018 | 398 | 0 | |||
| Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study | BJOG: an International Journal of Obstetrics and Gynaecology | 2018 | 430 | 227 | |||
| Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients | Thrombosis and Haemostasis | 2018 | 630 | 2 | |||
| Mutational epidemiology of congenital fibrinogen disorders | Thrombosis and Haemostasis | 2018 | 589 | 760 | |||
| Clinical prognosis of non-massive central and non-central pulmonary embolism: a registry-based cohort study | Chest | 2017 | 464 | 0 | |||
| The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women | Menopause | 2017 | 404 | 449 | |||
| Pharmacological management of pulmonary embolism | Expert Opinion on Pharmacotherapy | 2017 | 455 | 0 | |||
| Hormonal treatments and venous thrombosis in women | Revue médicale suisse | 2017 | 405 | 61 | |||
| Angiologie et hémostase | Revue médicale suisse | 2017 | 427 | 119 | |||
| Thromboprophylaxie hospitalière : doit-on adapter la dose d'énoxaparine au poids des patients ? | Revue médicale suisse | 2017 | 477 | 1 | |||
| Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review | Journal of Thrombosis and Haemostasis | 2017 | 589 | 0 | |||
| Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey | Thrombosis Research | 2017 | 391 | 1 | |||
| A clinical risk score to predict the incidence of postpartum venous thromboembolism | Evidence-Based Medicine | 2017 | 382 | 1 | |||
| Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women | Journal of Thrombosis and Haemostasis | 2017 | 423 | 223 | |||
| EpiMed: l'épidémiologie expliquée aux cliniciens | 2017 | 519 | 0 | ||||
| The association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use | Thrombosis and haemostasis | 2016 | 464 | 0 | |||
| Evolution des techniques d'imagerie dans le diagnostic de l'embolie pulmonaire | Revue médicale suisse | 2016 | 499 | 263 | |||
| Associations of Serum 25-Hydroxyvitamin D With Hemostatic and Inflammatory Biomarkers in the Multi-Ethnic Study of Atherosclerosis | The Journal of clinical endocrinology and metabolism | 2016 | 461 | 0 | |||
| Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes | Pharmacoepidemiology and drug safety | 2016 | 506 | 0 | |||
| The association of statin therapy with the risk of recurrent venous thrombosis | Journal of thrombosis and haemostasis | 2016 | 547 | 0 | |||
| Pre-pregnancy BMI, delivery BMI, gestational weight gain and the risk of postpartum venous thrombosis | Thrombosis research | 2016 | 545 | 0 | |||
| Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study | Menopause | 2016 | 441 | 0 | |||
| Excess Risk of Venous Thromboembolism Associated with Androgen Deprivation Therapy | European urology | 2016 | 477 | 0 | |||
| News in angiology and hemostasis | Revue médicale suisse | 2016 | 555 | 148 | |||
| Risks of venous thromboembolism after cesarean sections: A meta-analysis | Chest | 2016 | 488 | 0 | |||
| Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? | Schweizerische medizinische Wochenschrift | 2016 | 631 | 263 | |||
| Natural history of patients with congenital dysfibrinogenemia | Blood | 2015 | 735 | 4 | |||
| Secondary Prevention of Venous Thromboembolism: One Regimen May Not Fit All | Circulation | 2015 | 565 | 275 | |||
| Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis | PloS one | 2015 | 520 | 315 | |||
| Association Between Newborn Birthweight and the Risk of Postpartum Maternal Venous Thromboembolism: A Population-Based Case-Control Study | Circulation | 2015 | 586 | 0 | |||
| The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism. From the Women's Health Initiative Randomized Controlled Trial | Thrombosis and haemostasis | 2015 | 515 | 0 | |||
| Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis | The Lancet. Psychiatry | 2014 | 545 | 0 | |||
| Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers | Journal of thrombosis and haemostasis | 2014 | 431 | 0 | |||
| Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens | JAMA internal medicine | 2014 | 474 | 0 | |||
| Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis | Circulation. Heart failure | 2014 | 448 | 0 | |||
| 25-hydroxyvitamin D and parathyroid hormone levels do not predict changes in carotid arterial stiffness: the Multi-Ethnic Study of Atherosclerosis | Arteriosclerosis, thrombosis, and vascular biology | 2014 | 497 | 0 | |||
| Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study | Journal of thrombosis and haemostasis | 2014 | 484 | 0 | |||
| Predicting deep venous thrombosis in pregnancy : external validation of the LEFT clinical prediction rule | Haematologica | 2013 | 62 | 154 | |||
| Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study | British journal of haematology | 2013 | 451 | 0 | |||
| The association of smoking with venous thrombosis in women. A population-based, case-control study | Thrombosis and haemostasis | 2013 | 466 | 0 | |||
| Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy | Journal of thrombosis and haemostasis | 2013 | 419 | 0 | |||
| Utilité d'une anticoagulation avant le diagnostic définitif d'embolie pulmonaire | Revue médicale suisse | 2013 | 538 | 0 | |||
| 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis | Arteriosclerosis, thrombosis, and vascular biology | 2013 | 487 | 0 | |||
| Fondaparinux for isolated superficial vein thrombosis of the legs: a cost-effectiveness analysis | Chest | 2012 | 647 | 0 | |||
| Evaluation du risque hémorragique en cas de maladie thromboembolique veineuse: état des lieux en 2012 | Revue médicale suisse | 2012 | 535 | 0 | |||
| Usefulness of preemptive anticoagulation in patients with suspected pulmonary embolism: a decision analysis | Chest | 2012 | 673 | 1 | |||
| Stratégie diagnostique et intérêt comparatif des scores cliniques pour le diagnostic d'embolie pulmonaire | La Revue de médecine interne | 2010 | 595 | 0 | |||
| Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery | Thrombosis and haemostasis | 2010 | 644 | 0 | |||
| Treatment strategies for acute pulmonary embolism | Expert opinion on pharmacotherapy | 2009 | 606 | 0 | |||
| Approche diagnostique et prise en charge de la dissection aortique aiguë aux urgences : revue de la littérature | 2009 | 1,140 | 3,463 |
